Drug profile · INN
crofelemer
MYTESI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
crofelemer (MYTESI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN crofelemer
Brand MYTESI
Route ORAL
Formulation TABLET, DELAYED RELEASE
Frequently asked questions
What is crofelemer?
crofelemer (MYTESI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for crofelemer?
MYTESI is a marketed brand name for crofelemer. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of crofelemer?
crofelemer has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.